|
G |
Gli1 |
GLI family zinc finger 1 |
decreases expression |
ISO |
sonidegib results in decreased expression of GLI1 mRNA |
CTD |
PMID:24973920 |
|
NCBI chr 7:63,156,926...63,169,579
Ensembl chr 7:63,156,926...63,169,251
|
|
G |
Gli2 |
GLI family zinc finger 2 |
decreases expression decreases response to substance multiple interactions |
ISO |
sonidegib results in decreased expression of GLI2 mRNA GLI2 protein results in decreased susceptibility to sonidegib sonidegib inhibits the reaction [SUFU gene mutant form results in increased expression of GLI2 mRNA] |
CTD |
PMID:24973920 |
|
NCBI chr13:29,946,809...30,163,901
Ensembl chr13:29,946,809...30,163,574
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
increases phosphorylation |
EXP |
sonidegib results in increased phosphorylation of MTOR protein |
CTD |
PMID:31568847 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Mycn |
MYCN proto-oncogene, bHLH transcription factor |
decreases response to substance |
ISO |
MYCN protein results in decreased susceptibility to sonidegib |
CTD |
PMID:24973920 |
|
NCBI chr 6:35,717,764...35,723,590
Ensembl chr 6:35,717,764...35,723,590
|
|
G |
Smo |
smoothened, frizzled class receptor |
decreases response to substance |
ISO |
SMO protein mutant form results in decreased susceptibility to sonidegib |
CTD |
PMID:24973920 |
|
NCBI chr 4:58,344,101...58,372,828
Ensembl chr 4:58,343,529...58,373,829
|
|
G |
Sufu |
SUFU negative regulator of hedgehog signaling |
multiple interactions decreases response to substance |
ISO |
sonidegib inhibits the reaction [SUFU gene mutant form results in increased expression of GLI2 mRNA] SUFU gene mutant form results in decreased susceptibility to sonidegib |
CTD |
PMID:24973920 |
|
NCBI chr 1:245,257,725...245,355,576
Ensembl chr 1:245,257,768...245,355,577
|
|
|
G |
Agt |
angiotensinogen |
multiple interactions |
ISO |
HhAntag691 inhibits the reaction [AGT protein results in decreased expression of GLI3 protein]; HhAntag691 inhibits the reaction [AGT protein results in increased expression of GLI1 protein]; HhAntag691 inhibits the reaction [AGT protein results in increased expression of GLI2 protein]; HhAntag691 inhibits the reaction [AGT protein results in increased expression of SHH protein] |
CTD |
PMID:31181250 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions decreases expression |
ISO |
[GLI1 mRNA co-treated with GLI2 mRNA] affects the reaction [HhAntag691 results in decreased expression of BCL2 protein] |
CTD |
PMID:22087285 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Becn1 |
beclin 1 |
multiple interactions |
ISO |
HhAntag691 inhibits the reaction [nickel monoxide results in decreased expression of BECN1 protein] |
CTD |
PMID:34608745 |
|
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Casp3 |
caspase 3 |
increases cleavage |
ISO |
HhAntag691 results in increased cleavage of CASP3 protein |
CTD |
PMID:22087285 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression |
ISO |
HhAntag691 results in decreased expression of CCND1 mRNA |
CTD |
PMID:24973920 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccnd2 |
cyclin D2 |
decreases expression |
ISO |
HhAntag691 results in decreased expression of CCND2 mRNA |
CTD |
PMID:24973920 |
|
NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495
|
|
G |
Cdk6 |
cyclin-dependent kinase 6 |
decreases expression |
ISO |
HhAntag691 results in decreased expression of CDK6 mRNA |
CTD |
PMID:24973920 |
|
NCBI chr 4:30,637,650...30,829,688
Ensembl chr 4:30,646,460...30,829,634
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression multiple interactions |
ISO |
HhAntag691 results in increased expression of FAS protein [GLI1 mRNA co-treated with GLI2 mRNA] affects the reaction [HhAntag691 results in increased expression of FAS protein] |
CTD |
PMID:22087285 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Gli1 |
GLI family zinc finger 1 |
multiple interactions decreases expression |
ISO |
[GLI1 mRNA co-treated with GLI2 mRNA] affects the reaction [HhAntag691 results in decreased expression of BCL2 protein]; [GLI1 mRNA co-treated with GLI2 mRNA] affects the reaction [HhAntag691 results in decreased expression of PDGFRA protein]; [GLI1 mRNA co-treated with GLI2 mRNA] affects the reaction [HhAntag691 results in increased expression of FAS protein]; [GLI1 mRNA co-treated with GLI2 mRNA] affects the reaction [HhAntag691 results in increased expression of TNFRSF10A protein]; [GLI1 mRNA co-treated with GLI2 mRNA] affects the reaction [HhAntag691 results in increased expression of TNFRSF10B protein]; [GLI1 mRNA co-treated with GLI2 mRNA] affects the susceptibility to HhAntag691; HhAntag691 inhibits the reaction [AGT protein results in increased expression of GLI1 protein]; HhAntag691 inhibits the reaction [SHH protein results in increased expression of GLI1 mRNA] vismodegib decreases Gli1 protein expression in pituitary adenoma cells HhAntag691 results in decreased expression of GLI1 mRNA |
CTD RGD |
PMID:22087285 PMID:24973920 PMID:27585885 PMID:31181250 PMID:31642701 PMID:31519191 More...
|
RGD:150573695 |
NCBI chr 7:63,156,926...63,169,579
Ensembl chr 7:63,156,926...63,169,251
|
|
G |
Gli2 |
GLI family zinc finger 2 |
multiple interactions increases response to substance decreases expression decreases response to substance |
ISO |
[GLI1 mRNA co-treated with GLI2 mRNA] affects the reaction [HhAntag691 results in decreased expression of BCL2 protein]; [GLI1 mRNA co-treated with GLI2 mRNA] affects the reaction [HhAntag691 results in decreased expression of PDGFRA protein]; [GLI1 mRNA co-treated with GLI2 mRNA] affects the reaction [HhAntag691 results in increased expression of FAS protein]; [GLI1 mRNA co-treated with GLI2 mRNA] affects the reaction [HhAntag691 results in increased expression of TNFRSF10A protein]; [GLI1 mRNA co-treated with GLI2 mRNA] affects the reaction [HhAntag691 results in increased expression of TNFRSF10B protein]; [GLI1 mRNA co-treated with GLI2 mRNA] affects the susceptibility to HhAntag691; HhAntag691 inhibits the reaction [AGT protein results in increased expression of GLI2 protein] GLI2 gene mutant form results in increased susceptibility to HhAntag691 HhAntag691 results in decreased expression of GLI2 mRNA GLI2 protein results in decreased susceptibility to HhAntag691 GLI2 gene mutant form promotes the reaction [HhAntag691 inhibits the reaction [SHH protein results in increased expression of PTCH1 mRNA]]; HhAntag691 inhibits the reaction [SUFU gene mutant form results in increased expression of GLI2 mRNA] |
CTD |
PMID:22087285 PMID:24973920 PMID:27585885 PMID:31181250 |
|
NCBI chr13:29,946,809...30,163,901
Ensembl chr13:29,946,809...30,163,574
|
|
G |
Gli3 |
GLI family zinc finger 3 |
multiple interactions |
ISO |
HhAntag691 inhibits the reaction [AGT protein results in decreased expression of GLI3 protein] |
CTD |
PMID:31181250 |
|
NCBI chr17:49,438,567...49,709,712
Ensembl chr17:49,438,567...49,709,712
|
|
G |
Hhip |
Hedgehog-interacting protein |
decreases expression |
ISO |
HhAntag691 results in decreased expression of HHIP mRNA |
CTD |
PMID:24973920 |
|
NCBI chr19:27,863,684...27,952,528
Ensembl chr19:27,863,213...27,952,528
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
multiple interactions |
ISO |
HhAntag691 inhibits the reaction [nickel monoxide results in decreased lipidation of and results in decreased cleavage of MAP1LC3B protein] |
CTD |
PMID:34608745 |
|
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
|
|
G |
Mycn |
MYCN proto-oncogene, bHLH transcription factor |
decreases response to substance |
ISO |
MYCN protein results in decreased susceptibility to HhAntag691 |
CTD |
PMID:24973920 |
|
NCBI chr 6:35,717,764...35,723,590
Ensembl chr 6:35,717,764...35,723,590
|
|
G |
Pax6 |
paired box 6 |
increases expression |
ISO |
HhAntag691 results in increased expression of PAX6 mRNA |
CTD |
PMID:27585885 |
|
NCBI chr 3:92,128,772...92,157,022
Ensembl chr 3:92,135,637...92,157,014
|
|
G |
Pdgfra |
platelet derived growth factor receptor alpha |
multiple interactions decreases expression |
ISO |
[GLI1 mRNA co-treated with GLI2 mRNA] affects the reaction [HhAntag691 results in decreased expression of PDGFRA protein] |
CTD |
PMID:22087285 |
|
NCBI chr14:33,005,838...33,054,347
Ensembl chr14:33,005,839...33,054,335
|
|
G |
Prkaca |
protein kinase cAMP-activated catalytic subunit alpha |
increases expression |
ISO |
vismodegib increases protein kinase A protein expression in pituitary adenoma cells |
RGD |
PMID:31519191 |
RGD:150573695 |
NCBI chr19:24,155,081...24,178,430
Ensembl chr19:24,155,090...24,178,430
|
|
G |
Ptch1 |
patched 1 |
decreases expression multiple interactions |
ISO |
HhAntag691 results in decreased expression of PTCH1 mRNA GLI2 gene mutant form promotes the reaction [HhAntag691 inhibits the reaction [SHH protein results in increased expression of PTCH1 mRNA]]; HhAntag691 inhibits the reaction [SHH protein results in increased expression of PTCH1 mRNA] |
CTD |
PMID:22087285 PMID:24973920 PMID:27585885 |
|
NCBI chr17:1,542,705...1,607,730
Ensembl chr17:1,542,877...1,607,333
|
|
G |
Ptch2 |
patched 2 |
decreases expression |
ISO |
HhAntag691 results in decreased expression of PTCH2 mRNA |
CTD |
PMID:22087285 |
|
NCBI chr 5:130,571,956...130,592,506
Ensembl chr 5:130,572,312...130,592,405
|
|
G |
Shh |
sonic hedgehog signaling molecule |
decreases expression multiple interactions |
ISO |
HhAntag691 results in decreased expression of SHH mRNA HhAntag691 inhibits the reaction [AGT protein results in increased expression of SHH protein]; HhAntag691 inhibits the reaction [SHH protein results in increased expression of GLI1 mRNA] GLI2 gene mutant form promotes the reaction [HhAntag691 inhibits the reaction [SHH protein results in increased expression of PTCH1 mRNA]]; HhAntag691 inhibits the reaction [SHH protein results in increased expression of PTCH1 mRNA] |
CTD |
PMID:27585885 PMID:31181250 PMID:31642701 |
|
NCBI chr 4:6,954,017...6,963,170
Ensembl chr 4:6,954,017...6,963,170
|
|
G |
Smo |
smoothened, frizzled class receptor |
decreases expression decreases response to substance |
ISO |
HhAntag691 results in decreased expression of SMO mRNA SMO protein mutant form results in decreased susceptibility to HhAntag691 |
CTD |
PMID:22087285 PMID:24973920 |
|
NCBI chr 4:58,344,101...58,372,828
Ensembl chr 4:58,343,529...58,373,829
|
|
G |
Sqstm1 |
sequestosome 1 |
multiple interactions |
ISO |
HhAntag691 inhibits the reaction [nickel monoxide results in increased expression of SQSTM1 protein] |
CTD |
PMID:34608745 |
|
NCBI chr10:34,525,517...34,536,685
Ensembl chr10:34,525,519...34,536,673
|
|
G |
Sufu |
SUFU negative regulator of hedgehog signaling |
decreases response to substance increases expression multiple interactions |
ISO |
SUFU gene mutant form results in decreased susceptibility to HhAntag691 vismodegib increases SUFU protein expression in pituitary adenoma cells HhAntag691 inhibits the reaction [SUFU gene mutant form results in increased expression of GLI2 mRNA] |
CTD RGD |
PMID:24973920 PMID:31519191 |
RGD:150573695 |
NCBI chr 1:245,257,725...245,355,576
Ensembl chr 1:245,257,768...245,355,577
|
|
G |
Tnfrsf10b |
TNF receptor superfamily member 10b |
increases expression multiple interactions |
ISO |
HhAntag691 results in increased expression of TNFRSF10A protein [GLI1 mRNA co-treated with GLI2 mRNA] affects the reaction [HhAntag691 results in increased expression of TNFRSF10A protein] |
CTD |
PMID:22087285 |
|
NCBI chr15:44,839,818...44,867,582
Ensembl chr15:44,840,386...44,867,467
|
|